Because comparator groups often differ in treatment indication, disease duration and comorbidity profiles, residual confounding remains a primary concern, necessitating caution in causal inference. In a research letter published in Diabetes, Obesity and Metabolism , researchers obtained data from adults in the TriNetX database from January 2006 to October 2024
they are specific tools for specific jobs
It needs effective prevention and treatment
Cost, Access, and the Case for Compounded GLP-1 Wegovy's brand status creates artificial scarcity and high pricing that shifts costs to patients when insurance denies coverage or deductibles are unmet
Semaglutide is available as a once-daily oral tablet, which is currently the only FDA-approved GLP-1 pill for weight management
GLP-1 receptor agonists in PCOS: a systematic review and meta-analysis